10-K Decoder · All companies

Kiniksa Pharmaceuticals International, plc

KNSA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$678M$423M+60.1%
Operating income$77.2M−$45.6M
Net income$59.0M−$43.2M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 27, 2026

$Q3 2026Year earlierChange
Revenue$286M$181M+58.1%
Operating income$54.2M$24.0M+126%
Net income$47.3M$18.4M+157%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Kiniksa's revenue in FY2025?
$678M in FY2025 (Fiscal year ended Dec 31, 2025), +60.1% vs $423M a year earlier, per its 10-K filed Feb 2026.
Was Kiniksa profitable in FY2025?
Yes: net income was $59.0M and operating income $77.2M in FY2025.
What was Kiniksa's revenue in Q3 2026?
$286M (+58.1% vs a year earlier), per its Form 10-Q filed Oct 27, 2026.